Cannabinoid APIs (CBD)

Products

Information

The cannabinoid-based drug market is growing rapidly. To facilitate early-stage drug development in this emerging field of research, DSM has created an innovation platform, in partnership with Brains Bioceutical, to explore the full therapeutic potential of cannabinoid molecules, like cannabidiol (CBD).
Main Categories
APIs (Active Pharmaceutical Ingredients)Natural Extracts
All Categories
APIs (Active Pharmaceutical Ingredients)Natural ExtractsOther APIsPlant Extracts
dsm-firmenichAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet.

Log in

See all the content and easy-to-use features by logging in or registering!